Literature DB >> 20571503

A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1.

Alice Marques-Pinheiro1, Marie Marduel, Jean-Pierre Rabès, Martine Devillers, Ludovic Villéger, Delphine Allard, Jean Weissenbach, Maryse Guerin, Yassine Zair, Danièle Erlich, Claudine Junien, Arnold Munnich, Michel Krempf, Marianne Abifadel, Jean-Philippe Jaïs, Catherine Boileau, Mathilde Varret.   

Abstract

Autosomal dominant hypercholesterolemia (ADH) is characterized by isolated increase in plasmatic low-density lipoprotein (LDL) cholesterol levels associated with high risk of premature cardiovascular disease. Mutations in LDLR, APOB, and PCSK9 genes have been shown to cause ADH. We now report further genetic heterogeneity of ADH through the study of a large French family in which the involvement of these three genes was excluded. A genome-wide scan mapped the disease-causing gene, named HCHOLA4, at 16q22.1 in a 7.89-Mb interval containing 154 genes with a maximum LOD score of 3.9. To reduce the linked region, we genotyped 18 smaller non-LDLR/non-APOB/non-PCSK9-ADH families at the HCHOLA4 locus. Six families did not exclude linkage to the locus, but none allowed reduction of the disease interval. The 154 regional genes were sorted according to the function of the encoded protein and tissue expression profiles, and 57 genes were analyzed through sequencing of their coding region and close flanking intronic parts. No disease-causing mutation was identified in these families, particularly in the LCAT gene. Finally, our results also show the existence of other ADH genes as nine families were neither linked to LDLR, APOB, and PCSK9 genes nor to the new HCHOLA4 locus.

Entities:  

Mesh:

Year:  2010        PMID: 20571503      PMCID: PMC2987478          DOI: 10.1038/ejhg.2010.94

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  35 in total

1.  Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body.

Authors:  Markus Babst; David J Katzmann; William B Snyder; Beverly Wendland; Scott D Emr
Journal:  Dev Cell       Date:  2002-08       Impact factor: 12.270

2.  Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network.

Authors:  Balraj Doray; Pradipta Ghosh; Janice Griffith; Hans J Geuze; Stuart Kornfeld
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

3.  Isolation, characterization, and assay of lecithin-cholesterol acyltransferase.

Authors:  J J Albers; C H Chen; A G Lacko
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

Review 4.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

5.  Computer programs for multilocus haplotyping of general pedigrees.

Authors:  D E Weeks; E Sobel; J R O'Connell; K Lange
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

6.  Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.

Authors:  L F Soria; E H Ludwig; H R Clarke; G L Vega; S M Grundy; B J McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol.

Authors:  J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

8.  Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.

Authors:  H H Hobbs; E Leitersdorf; C C Leffert; D R Cryer; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

9.  Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia.

Authors:  C Sass; L M Giroux; Y Ma; M Roy; J Lavigne; S Lussier-Cacan; J Davignon; A Minnich
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

10.  A second locus for Marfan syndrome maps to chromosome 3p24.2-p25.

Authors:  G Collod; M C Babron; G Jondeau; M Coulon; J Weissenbach; O Dubourg; J P Bourdarias; C Bonaïti-Pellié; C Junien; C Boileau
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

View more
  13 in total

Review 1.  Genetics of familial hypercholesterolemia.

Authors:  Ariel Brautbar; Emili Leary; Kristen Rasmussen; Don P Wilson; Robert D Steiner; Salim Virani
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

2.  Mutation in the PCSK9 Gene in Omani Arab Subjects with Autosomal Dominant Hypercholesterolemia and its Effect on PCSK9 Protein Structure.

Authors:  Khalid Al-Waili; Ward Al-Muna Al-Zidi; Abdul Rahim Al-Abri; Khalid Al-Rasadi; Hilal Ali Al-Sabti; Karna Shah; Abdullah Al-Futaisi; Ibrahim Al-Zakwani; Yajnavalka Banerjee
Journal:  Oman Med J       Date:  2013-01

3.  Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.

Authors:  René Wintjens; Dominique Bozon; Khaldia Belabbas; Félicien MBou; Jean-Philippe Girardet; Patrick Tounian; Mathilde Jolly; Franck Boccara; Ariel Cohen; Alexandra Karsenty; Béatrice Dubern; Jean-Claude Carel; Ahlam Azar-Kolakez; François Feillet; François Labarthe; Anne-Marie Colin Gorsky; Alice Horovitz; Catherine Tamarindi; Pierre Kieffer; Anne Lienhardt; Olivier Lascols; Mathilde Di Filippo; Fabienne Dufernez
Journal:  J Lipid Res       Date:  2016-01-22       Impact factor: 5.922

4.  Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.

Authors:  Marie Marduel; Khadija Ouguerram; Valérie Serre; Dominique Bonnefont-Rousselot; Alice Marques-Pinheiro; Knut Erik Berge; Martine Devillers; Gérald Luc; Jean-Michel Lecerf; Laurent Tosolini; Danièle Erlich; Gina M Peloso; Nathan Stitziel; Patrick Nitchké; Jean-Philippe Jaïs; Marianne Abifadel; Sekar Kathiresan; Trond Paul Leren; Jean-Pierre Rabès; Catherine Boileau; Mathilde Varret
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

5.  Novel and recurrent LDLR gene mutations in Pakistani hypercholesterolemia patients.

Authors:  Waqas Ahmed; Muhammad Ajmal; Ahmed Sadeque; Roslyn A Whittall; Sobia Rafiq; Wendy Putt; Athar Khawaja; Fauzia Imtiaz; Nuzhat Ahmed; Maleeha Azam; Steve E Humphries; Raheel Qamar
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

6.  Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.

Authors:  Awatef Jelassi; Mohamed Najah; Afef Slimani; Imen Jguirim; Mohamed Naceur Slimane; Mathilde Varret
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

7.  Molecular spectrum of autosomal dominant hypercholesterolemia in France.

Authors:  Marie Marduel; Alain Carrié; Agnes Sassolas; Martine Devillers; Valérie Carreau; Mathilde Di Filippo; Danièle Erlich; Marianne Abifadel; Alice Marques-Pinheiro; Arnold Munnich; Claudine Junien; Catherine Boileau; Mathilde Varret; Jean-Pierre Rabès
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

Review 8.  Identifying Highly Penetrant Disease Causal Mutations Using Next Generation Sequencing: Guide to Whole Process.

Authors:  A Mesut Erzurumluoglu; Santiago Rodriguez; Hashem A Shihab; Denis Baird; Tom G Richardson; Ian N M Day; Tom R Gaunt
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

9.  Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation.

Authors:  Nabil G Seidah; Steve Poirier; Maxime Denis; Rex Parker; Bowman Miao; Claudio Mapelli; Annik Prat; Hanny Wassef; Jean Davignon; Katherine A Hajjar; Gaétan Mayer
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.

Authors:  Marta Futema; Vincent Plagnol; KaWah Li; Ros A Whittall; H Andrew W Neil; Mary Seed; Stefano Bertolini; Sebastiano Calandra; Olivier S Descamps; Colin A Graham; Robert A Hegele; Fredrik Karpe; Ronen Durst; Eran Leitersdorf; Nicholas Lench; Devaki R Nair; Handrean Soran; Frank M Van Bockxmeer; Steve E Humphries
Journal:  J Med Genet       Date:  2014-07-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.